Header Logo

Connection

STACEY BERG to Vascular Endothelial Growth Factor A

Back to Details
This is a "connection" page, showing publications STACEY BERG has written about Vascular Endothelial Growth Factor A.
STACEY BERG
Connection Strength
0.047
Vascular Endothelial Growth Factor A
  1. A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumors. Pediatr Blood Cancer. 2024 Mar; 71(3):e30817.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.